Role of TXA in Patients Undergoing Breast Free Flap Reconstruction

Summary

Tranexamic acid (TXA) is a synthetic, competitive lysine receptor inhibitor on plasminogen. It ultimately stabilizes the fibrin matrix, therefore used as a hemostatic agent for various indications. While there has been indications for orthopedic and trauma surgery, there is no clear data for its role in patients who are undergoing free tissue transfer. Studies have shown that patients undergoing free tissue transfer can have transfusion rates ranging from 7.2% to 34.9%, which data also showing association between transfusion requirement and higher free flap failure rate. There has been a few retrospective studies that evaluated the effect of TXA in free tissue transfer and the results showed no increased risk of microanastomosis failure but some showing decreased blood loss. This study aims to further analyze the role of TXA in patients undergoing breast free flap reconstruction with randomized, prospective trial. Control group will not receive TXA while experimental group will receive TXA. Both groups will receive standard of care breast free flap surgery as well as post-op care, which is streamlined with Early Recovery After Surgery (ERAS) protocol. Their pre and post-op hemoglobin will be compared, as well as rates of transfusion, surgical outcome and surgical complications including hematoma, flap failure, and any other medical complications such as Deep Vein Thrombosis (DVT)/ Pulmonary Embolism (PE).

Eligibility

Inclusion Criteria:

* All female patients who are 18 years or older who will undergo unilateral or bilateral abdomen-based free flap breast reconstruction at UVA Medical Center

Exclusion Criteria:

* Subjects with ages \<18 years
* Allergy to TXA
* Subjects who has contraindications to TXA: anyone who has active intravascular thrombosis or anyone with subarachnoid hemorrhage
* Subjects who have anemia (defined as baseline hemoglobin \<8 g/dL
* Subjects who cannot read or understand English
* Subjects who are pregnant

Conditions3

Interventions1

Locations1 site

Find trials near these locations

Related trials

• Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial — RenJi Hospital
• Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia — University of Manitoba
• Perioperative Treatment With Tranexamic Acid in Melanoma — University of Aarhus
• Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial) — Ottawa Hospital Research Institute
• Tranexamic Acid During Colonic Endoscopic Resection Procedures — Assaf-Harofeh Medical Center
• Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients — Second Affiliated Hospital, School of Medicine, Zhejiang University
• The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients — Stanford University
• A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients — M.D. Anderson Cancer Center

Browse More Trials